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Remission turned out to be a divider between good of
poor outcome in a study where 242 patients with schiz-
opsychotic illness were assessed. The study took place at
the NU Health Care in the western region of Sweden and
in total 284 patients were enrolled in this single centre
study of which 242 completed the different tests. The
number of patients is more than 50% of all patients in the
catchment area who are in a stable condition.
All patients were tested to decide the illness severity, func-
tional and social outcome, cognitive capacity, quality of
life, satisfaction of care, insight, family burden, received
pharmacological treatment and side-effects. The status of
remission was assessed by extracting the eight items from
the PANSS (Positive And Negative Syndrome Scale).
In total 38% of the patients has achieved the severity cri-
teria for remission. These patients were superior in both
functional and social outcome. They also reported a better
quality of life as well as their relatives perceived fewer bur-
dens as a consequence of the illness. They expired a higher
satisfaction with their care and antipsychotic treatment
and finally showed a better understanding of their illness.
A parallel finding was that patients who had reached
remission also had a better cognitive ability.
Our findings suggest that patients in remission has a favo-
rable outcome in such extent that remission must be iden-
tified as a primary treatment goal. On the other hand, the
likelihood of remission seems to be related to the patient's
level of cognitive functioning. This enhances the impor-
tance of providing a treatment that allows patients with
not so good ability to achieve remission and a better out-
come.
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